ライフサイエンスコーパス: buccal mucosa

1 ocytes, urinary epithelial cells (UECs), and buccal mucosa.

2 tion occurred across inflamed but not normal buccal mucosa.

3 lesions, but also in grossly normal adjacent buccal mucosa.

4 rboring the mutation in her blood, skin, and buccal mucosa.

5 s of the surface of the dorsal tongue or the buccal mucosa.

6 the superficial squamous cell layers of the buccal mucosa.

7 connective tissue of the facial flap to the buccal mucosa.

8 e skin biopsy, as well as from the patient's buccal mucosa.

9 ne were initiated at three sites through the buccal mucosa: 1) 6 mm apical to the cemento-enamel junc

10 n blood (15%), urinary epithelium (75%), and buccal mucosa (58%).

11 and, surprisingly, also in normal-appearing buccal mucosa adjacent to HNSCC (see the related article

12 membrane (blister formation) of normal human buccal mucosa, after 48 hours, in organ culture.

13 were compared, to optimize cellular yield in buccal mucosa and cornea.

14 major salivary glands, tongue, gingiva, and buccal mucosa and detected beta-defensin peptides in sal

15 to have tongue malignancy (82%) followed by buccal mucosa and gingivobuccal sulcus malignancy (18%).

16 tract and by pigmented macules of the lips, buccal mucosa, and digits.

17 the m.14487T>C mutation in his blood, urine, buccal mucosa, and hair follicle DNA samples, while the

18 in plaque, others in keratinized gingiva or buccal mucosa, and some oligotypes were characteristic o

19 was detected in the gingiva, parotid gland, buccal mucosa, and tongue.

20 amples from the tongue, tonsils, throat, and buccal mucosa; and stimulated and unstimulated saliva.

21 The buccal mucosa appeared as an intermediate ecological nic

22 s, we have investigated the potential of the buccal mucosa as an alternative delivery route for ShK b

23 ening sites included the forehead, nostrils, buccal mucosa, axilla, antecubital fossa, groin, and toe

24 ted AKT (pAKT) in 15 paired tumor, skin, and buccal mucosa biopsies (at baseline and after 1 month of

25 om LL explants compared to explants from the buccal mucosa (BM), HP, and transition zone of the lower

26 objective was to monitor lycopene changes in buccal mucosa cells (BMCs) in response to 3 vehicles for

27 ion protein Cx43 were markedly diminished in buccal mucosa cells from arrhythmogenic cardiomyopathy p

28 Buccal mucosa cells from arrhythmogenic cardiomyopathy p

29 esmosomal protein desmoplakin was reduced in buccal mucosa cells from patients with mutations in DSP,

30 mosomal protein plakophilin-1 was reduced in buccal mucosa cells in patients with PKP2 mutations but

31 Inhibition of prelamin A farnesylation in buccal mucosa cells of patients treated with SCH66336 wa

32 , and 15 wk and 2 mo after the study, serum, buccal mucosa cells, and adipose tissue were analyzed fo

33 By comparing the DNA from leukemic cells to buccal mucosa cells, LOH was detected with markers D5S47

34 patients, the mutation was also detected in buccal mucosa cells.

35 potential surrogate tissue, we characterized buccal mucosa cells.

36 unfixed methods applied to exfoliated oral (buccal) mucosa cells.

37 including decreases in microcirculations of buccal mucosa, cerebral microvascular flow was preserved

38 A body tissue that is easy to access is the buccal mucosa (cheek cells).

39 The delivery of drugs through the buccal mucosa has attracted much research interest over

40 aps more germane to epithelial malignancies, buccal mucosa have provided surrogate tissues that allow

41 This study demonstrated that the buccal mucosa is a promising administration route for th

42 ups based on similar community compositions: buccal mucosa, keratinized gingiva, hard palate; saliva,

43 (+) cells equally distributed throughout the buccal mucosa of OPC(-) persons (HIV(-) or HIV(+)), irre

44 elialized surface of the facial flap and the buccal mucosa of the vestibule.

45 of selegiline, which is absorbed through the buccal mucosa producing higher plasma levels of selegili

46 c verrucous papules on the lips, tongue, and buccal mucosa refractory to multiple excisions.

47 th the best sensitivity were the leg and the buccal mucosa, respectively (82.6% and 52.2%; P = 0.003)

48 Buccal mucosa samples and peripheral blood mononuclear c

49 ue derived from lymphoblastoid cell lines or buccal mucosa scrapings.

50 f fluorescent 5-Fam-ShK to untreated porcine buccal mucosa, there was no detectable peptide in the re

51 f the attached gingiva, alveolar mucosa, and buccal mucosa to gain insight into human tissue performa

52 f PBD-1 in the dorsal tongue surface and the buccal mucosa was estimated at 20 to 100 micrograms/ml.

53 nactivation patterns in peripheral blood and buccal mucosa were compared between monochorionic MZ (MC